Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Perrigo invests £2.4 million in Dermalex campaign

Perrigo has invested £2.4 million in its "biggest budget campaign" for the Dermalex range yet, the manufacturer has announced.

A six-week television campaign will air from February 19 across "main broadcast channels", focusing on Dermalex’s eczema treatment, Perrigo said.

Subsequent activity focusing on its rosacea treatment – including print adverts in national newspapers and consumer magazines – will begin in April and run for eight weeks, with a “third peak of activity” of 12 weeks launching in September.

Training materials focusing on these skin conditions will be rolled out to pharmacies across the country to support pharmacy staff, Perrigo added.

Holly Turner, senior marketing director at Perrigo, said: “Dermalex’s previous marketing campaign, which featured TV, social, PR and pharmacy trade activity, was a huge success and we’re excited to build on this momentum throughout 2018.”

Dermalex Atopic Eczema Treatment has an RRP of £11.99 for 30g, and £24.99 for 100g.

To order the Dermalex range, contact 0800 1216 909

Will you order this product?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD009155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel